BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17969105)

  • 1. NR1 and GluR2 expression mediates excitotoxicity in chronic hypobaric hypoxia.
    Hota SK; Barhwal K; Singh SB; Sairam M; Ilavazhagan G
    J Neurosci Res; 2008 Apr; 86(5):1142-52. PubMed ID: 17969105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection.
    Radenovic L; Selakovic V
    Brain Res Bull; 2005 Sep; 67(1-2):133-41. PubMed ID: 16140172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMDA receptor-mediated excitotoxicity contributes to the cerebral hypoxic injury of a rat model of posthypoxic myoclonus.
    Tai KK; Truong DD
    Brain Res; 2007 Feb; 1133(1):209-15. PubMed ID: 17196560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of a non-NMDA antagonist, GYKI 52466, increases excitotoxic Purkinje cell degeneration caused by ibogaine.
    O'Hearn E; Molliver ME
    Neuroscience; 2004; 127(2):373-83. PubMed ID: 15262328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.
    Karanian DA; Baude AS; Brown QB; Parsons CG; Bahr BA
    Hippocampus; 2006; 16(10):834-42. PubMed ID: 16897723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential neuronal fates in the CA1 hippocampus after hypoxia in newborn and 7-day-old rats: effects of pre-treatment with MK-801.
    Grojean S; Pourié G; Vert P; Daval JL
    Hippocampus; 2003; 13(8):970-7. PubMed ID: 14750659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate and regulation of proliferation in the developing mammalian telencephalon.
    Luk KC; Sadikot AF
    Dev Neurosci; 2004; 26(2-4):218-28. PubMed ID: 15711062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse galectin-1 inhibits the toxicity of glutamate by modifying NR1 NMDA receptor expression.
    Lekishvili T; Hesketh S; Brazier MW; Brown DR
    Eur J Neurosci; 2006 Dec; 24(11):3017-25. PubMed ID: 17156363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate N-methyl-D-aspartate and dopamine receptors have contrasting effects on the limbic versus the somatosensory cortex with respect to amphetamine-induced neurodegeneration.
    Bowyer JF; Delongchamp RR; Jakab RL
    Brain Res; 2004 Dec; 1030(2):234-46. PubMed ID: 15571672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired glutamine metabolism in NMDA receptor hypofunction induced by MK801.
    Brenner E; Kondziella D; Håberg A; Sonnewald U
    J Neurochem; 2005 Sep; 94(6):1594-603. PubMed ID: 16045441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stretch-induced injury in organotypic hippocampal slice cultures reproduces in vivo post-traumatic neurodegeneration: role of glutamate receptors and voltage-dependent calcium channels.
    Cater HL; Gitterman D; Davis SM; Benham CD; Morrison B; Sundstrom LE
    J Neurochem; 2007 Apr; 101(2):434-47. PubMed ID: 17250683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
    Heath PR; Shaw PJ
    Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic neuroprotection by bis(7)-tacrine via concurrent blockade of N-methyl-D-aspartate receptors and neuronal nitric-oxide synthase.
    Li W; Xue J; Niu C; Fu H; Lam CS; Luo J; Chan HH; Xue H; Kan KK; Lee NT; Li C; Pang Y; Li M; Tsim KW; Jiang H; Chen K; Li X; Han Y
    Mol Pharmacol; 2007 May; 71(5):1258-67. PubMed ID: 17299028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
    Tanović A; Alfaro V
    Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide produced by non-motoneuron cells enhances rat embryonic motoneuron sensitivity to excitotoxins: comparison in mixed neuron/glia or purified cultures.
    Comoletti D; Muzio V; Capobianco A; Ravizza T; Mennini T
    J Neurol Sci; 2001 Nov; 192(1-2):61-9. PubMed ID: 11701154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition.
    Domercq M; Etxebarria E; Pérez-Samartín A; Matute C
    Glia; 2005 Oct; 52(1):36-46. PubMed ID: 15892126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered excitability and distribution of NMDA receptor subunit proteins in cortical layers of rat pups following multiple perinatal seizures.
    Gashi E; Avallone J; Webster T; Friedman LK
    Brain Res; 2007 May; 1145():56-65. PubMed ID: 17320824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excitotoxic mechanisms of ischemic injury in myelinated white matter.
    Tekkök SB; Ye Z; Ransom BR
    J Cereb Blood Flow Metab; 2007 Sep; 27(9):1540-52. PubMed ID: 17299453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the glutamatergic receptors (AMPA and NMDA) and of glutamate vesicular transporter 2 in the rat facial nucleus after axotomy.
    Eleore L; Vassias I; Vidal PP; de Waele C
    Neuroscience; 2005; 136(1):147-60. PubMed ID: 16182453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitatory amino acid receptors and neurodegeneration.
    Doble A
    Therapie; 1995; 50(4):319-37. PubMed ID: 7482387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.